pubmed-article:20044996 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20044996 | lifeskim:mentions | umls-concept:C0021368 | lld:lifeskim |
pubmed-article:20044996 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:20044996 | lifeskim:mentions | umls-concept:C0009368 | lld:lifeskim |
pubmed-article:20044996 | lifeskim:mentions | umls-concept:C0024432 | lld:lifeskim |
pubmed-article:20044996 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:20044996 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:20044996 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:20044996 | pubmed:dateCreated | 2010-3-29 | lld:pubmed |
pubmed-article:20044996 | pubmed:abstractText | Infection with the rat tapeworm Hymenolepis diminuta reduces the severity of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice. Infection with H. diminuta increases colonic expression of arginase-1 and found in inflammatory zone 1 (FIZZ1), markers of alternatively activated macrophages (AAMs). We investigated whether AAMs have anticolitic effects. | lld:pubmed |
pubmed-article:20044996 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:language | eng | lld:pubmed |
pubmed-article:20044996 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20044996 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20044996 | pubmed:month | Apr | lld:pubmed |
pubmed-article:20044996 | pubmed:issn | 1528-0012 | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:BeckPaul LPL | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:McKayDerek... | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:WangArthurA | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:HunterMeaghan... | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:ParharKuljit... | lld:pubmed |
pubmed-article:20044996 | pubmed:author | pubmed-author:JohnstonMicha... | lld:pubmed |
pubmed-article:20044996 | pubmed:copyrightInfo | 2010 AGA Institute. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:20044996 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20044996 | pubmed:volume | 138 | lld:pubmed |
pubmed-article:20044996 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20044996 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20044996 | pubmed:pagination | 1395-405 | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:meshHeading | pubmed-meshheading:20044996... | lld:pubmed |
pubmed-article:20044996 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20044996 | pubmed:articleTitle | In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. | lld:pubmed |
pubmed-article:20044996 | pubmed:affiliation | Intestinal Disease Research Program, McMaster University, Hamilton, Ontario, Canada. | lld:pubmed |
pubmed-article:20044996 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20044996 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20044996 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20044996 | lld:pubmed |